Mesoblast (MESO) Total Current Liabilities (2015 - 2025)

Mesoblast has disclosed Total Current Liabilities across 11 years of filings, most recently posting $128.1 million for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $128.1 million, up 76.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $128.1 million (up 76.04% YoY), and the FY2025 annual result was $102.6 million, up 40.12% from the prior year.
• Total Current Liabilities came in at $128.1 million for Q4 2025 at Mesoblast, up from $102.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $128.1 million in Q4 2025 to a low of $31.4 million in Q4 2023.
• The 5-year median for Total Current Liabilities is $58.0 million (2021), against an average of $70.3 million.
• Across the five-year window, Total Current Liabilities plunged 47.47% in 2022 and surged 131.93% in 2024, its largest moves.
• Mesoblast's Total Current Liabilities stood at $58.0 million in 2021, then decreased by 5.83% to $54.6 million in 2022, then plunged by 42.53% to $31.4 million in 2023, then soared by 131.93% to $72.8 million in 2024, then soared by 76.04% to $128.1 million in 2025.
• The last three Total Current Liabilities figures came in at $128.1 million (Q4 2025), $102.6 million (Q2 2025), and $72.8 million (Q4 2024), per Business Quant data.